---
title: "AKKARAJU SRINIVAS — Ownership Dossier"
canonical: https://whiteintel.dev/entity/ec9ac26b-07ce-5595-b013-3e7386eb27ef
json: https://whiteintel.dev/api/public/dossier/ec9ac26b-07ce-5595-b013-3e7386eb27ef
identifier: sec:0001253170
jurisdiction: US
risk: Medium
source: WhiteIntel corporate-ownership graph
---

# AKKARAJU SRINIVAS

**Type:** Person  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001253170`  
**Risk level:** Medium  
**Canonical dossier:** https://whiteintel.dev/entity/ec9ac26b-07ce-5595-b013-3e7386eb27ef  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/ec9ac26b-07ce-5595-b013-3e7386eb27ef  

## Ownership & control

### Holdings / subsidiaries

- **Kalaris Therapeutics, Inc.** (10% owner) — https://whiteintel.dev/entity/de4c956a-976e-5209-89f2-2f72662ee99d
- **Kalaris Therapeutics, Inc.** (10% owner) — https://whiteintel.dev/entity/de4c956a-976e-5209-89f2-2f72662ee99d
- **Kalaris Therapeutics, Inc.** (10% owner) — https://whiteintel.dev/entity/de4c956a-976e-5209-89f2-2f72662ee99d
- **Mineralys Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/ce1db34b-b2dd-51bb-8605-d58190624d9b
- **Mineralys Therapeutics, Inc.** (10% owner) — https://whiteintel.dev/entity/ce1db34b-b2dd-51bb-8605-d58190624d9b
- **vTv Therapeutics Inc.** (director) — https://whiteintel.dev/entity/353f31f2-6045-5ec1-8144-e0547fb20612
- **Scholar Rock Holding Corp** (director) — https://whiteintel.dev/entity/c00d869b-d1d7-5f97-a644-d655f00e7e34
- **Kalaris Therapeutics, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/de4c956a-976e-5209-89f2-2f72662ee99d
- **Kalaris Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/de4c956a-976e-5209-89f2-2f72662ee99d
- **Mineralys Therapeutics, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/ce1db34b-b2dd-51bb-8605-d58190624d9b
- **ALUMIS INC.** (director) — https://whiteintel.dev/entity/374cc9a3-2ffd-577a-9e35-4d9b311fae1d
- **Mineralys Therapeutics, Inc.** (director) — https://whiteintel.dev/entity/ce1db34b-b2dd-51bb-8605-d58190624d9b
- **Neurogene Inc.** (tenpercentowner) — https://whiteintel.dev/entity/7be59bde-4b7a-572c-ada1-6fee523070a6
- **vTv Therapeutics Inc.** (tenpercentowner) — https://whiteintel.dev/entity/353f31f2-6045-5ec1-8144-e0547fb20612
- **LS22, INC.** (director) — https://whiteintel.dev/entity/3e598953-a994-5c75-bab0-550d6c26ea32
- **CARGO Therapeutics, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/a783c33b-8f92-53e0-844a-0233eef54b40
- **INTERCEPT PHARMACEUTICALS INC** (director) — https://whiteintel.dev/entity/7e041d37-2a0c-51c6-8d1f-e81aa7212ab3
- **Scholar Rock Holding Corp** (tenpercentowner) — https://whiteintel.dev/entity/c00d869b-d1d7-5f97-a644-d655f00e7e34
- **ADURO BIOTECH** (director) — https://whiteintel.dev/entity/f0706f3b-297f-58aa-9fc7-e760403b244e
- **JIYA ACQUISITION CORP.** (director) — https://whiteintel.dev/entity/228ed576-0d79-59dc-a084-a10c71c02530
- **JIYA ACQUISITION CORP.** (tenpercentowner) — https://whiteintel.dev/entity/228ed576-0d79-59dc-a084-a10c71c02530
- **LENZ Therapeutics, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/52024eeb-7411-50be-bf00-889ef1323af1
- **SEAGEN INC.** (director) — https://whiteintel.dev/entity/c5825089-63d5-5f88-83d5-fd3fc54d96d0
- **ARAVIVE, INC.** (other) — https://whiteintel.dev/entity/d9db5d78-27d3-56e4-af4a-21772a728057
- **ARAVIVE, INC.** (director) — https://whiteintel.dev/entity/d9db5d78-27d3-56e4-af4a-21772a728057
- **PRINCIPIA BIOPHARMA INC.** (director) — https://whiteintel.dev/entity/6a36d913-a2d3-50be-abc9-858acd647053
- **aTYR PHARMA INC** (director) — https://whiteintel.dev/entity/7d0875a2-005c-5837-b4fa-bd6cd0d6d971
- **SYNLOGIC, INC.** (tenpercentowner) — https://whiteintel.dev/entity/cb1fffff-5c7c-5391-9033-d8ad77862369
- **Aclaris Therapeutics, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/c45df1a6-3c2b-5356-8610-13c79a350a65
- **ZS PHARMA, INC.** (director) — https://whiteintel.dev/entity/5542e8fd-1553-5dde-98c3-ed0e806fb512
- **aTYR PHARMA INC** (directorother) — https://whiteintel.dev/entity/7d0875a2-005c-5837-b4fa-bd6cd0d6d971
- **aTYR PHARMA INC** (tenpercentowner) — https://whiteintel.dev/entity/7d0875a2-005c-5837-b4fa-bd6cd0d6d971
- **SPARK THERAPEUTICS, INC.** (tenpercentowner) — https://whiteintel.dev/entity/b04b64c0-8599-5332-a83b-9b3643690dbd
- **Ocugen, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/7bdadd7e-6956-5e3d-b81c-c17d350922b9
- **ALIMERA SCIENCES INC** (tenpercentowner) — https://whiteintel.dev/entity/7d2efdb1-0a0d-5c94-ad59-fe2239278452
- **ARAVIVE, INC.** (tenpercentowner) — https://whiteintel.dev/entity/d9db5d78-27d3-56e4-af4a-21772a728057
- **LITE STRATEGY, INC.** (tenpercentowner) — https://whiteintel.dev/entity/c3772b71-5536-52ed-890a-0af01a319977
- **DURATA THERAPEUTICS, INC.** (tenpercentowner) — https://whiteintel.dev/entity/c9ad4838-557e-5e50-8482-6030f8b61325
- **WORLD HEART CORP** (tenpercentowner) — https://whiteintel.dev/entity/7d855733-6a95-592e-a869-c0eb3346367a
- **SYNAGEVA BIOPHARMA CORP** (other) — https://whiteintel.dev/entity/aabad33f-5398-5580-80ed-e469622973b8
- **SYNAGEVA BIOPHARMA CORP** (director) — https://whiteintel.dev/entity/aabad33f-5398-5580-80ed-e469622973b8
- **ICAGEN INC** (other) — https://whiteintel.dev/entity/8bb5d6ec-5781-5fdd-9c3f-f7fb56b4f2c3
- **NOVACEA INC** (other) — https://whiteintel.dev/entity/ae254050-c680-5a04-8774-2e41a4af64eb
- **NOVACEA INC** (tenpercentowner) — https://whiteintel.dev/entity/ae254050-c680-5a04-8774-2e41a4af64eb
- **PHARMOS CORP** (director) — https://whiteintel.dev/entity/87f55379-64b9-5f84-92ce-db90ad4c010a
- **BARRIER THERAPEUTICS INC** (director) — https://whiteintel.dev/entity/4483e3bf-e6b7-5213-8cab-91f956404c66

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **AKKARAJU SRINIVAS**. Human view: https://whiteintel.dev/entity/ec9ac26b-07ce-5595-b013-3e7386eb27ef · Structured JSON: https://whiteintel.dev/api/public/dossier/ec9ac26b-07ce-5595-b013-3e7386eb27ef._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._